# Study of the Efficacy and Safety of BCD-089 in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis

> **NCT04227366** · PHASE3 · COMPLETED · sponsor: **Biocad** · enrollment: 154 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** BCD-089
- **BIOLOGICAL:** Placebo
- **DRUG:** Methotrexat

## Key facts

- **NCT ID:** NCT04227366
- **Lead sponsor:** Biocad
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-19
- **Primary completion:** 2021-03-15
- **Final completion:** 2022-03-01
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2022-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04227366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04227366, "Study of the Efficacy and Safety of BCD-089 in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04227366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*